CAR-T Cell Therapy: Fighting Fire with Fire
April Rahrig, DO
Fellow, Pediatric Hematology Oncology
Riley Hospital for Children at IU Health
Indiana University School of Medicine
Jodi Skiles, MD MS
Associate Professor of Pediatrics
Director, Pediatric Stem Cell Transplant and Cellular Therapy
Fellowship Program Director
Pediatric Hematology/Oncology
Riley Hospital for Children at IU Health
Indiana University School of Medicine
Learning Objectives
At the conclusion of the conference, learners will be able to:
• Understand the mechanism of action of CAR-T cells
• Identify indications for the use of CAR-T cell therapy
• Recognize the adverse events associated with CAR-T cell therapy including cytokine release syndrome, neurotoxicity and B Cell aplasia
